AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2018
Nov 21, 2018
33298_dirs_2018-11-21_e9cc5ebc-6324-483c-9101-367a6ceb6209.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2018-11-20
Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-20 | Common Stock, par value $0.01 | P | 1500 | $0.1487 | Acquired | 2971693 | Indirect |
| 2018-11-20 | Common Stock, par value $0.01 | P | 4900 | $0.1698 | Acquired | 2976593 | Indirect |
| 2018-11-20 | Common Stock, par value $0.01 | P | 14206 | $0.15 | Acquired | 2990799 | Indirect |
| 2018-11-20 | Common Stock, par value $0.01 | P | 8250 | $0.172 | Acquired | 2999049 | Indirect |
| 2018-11-20 | Common Stock, par value $0.01 | P | 1750 | $0.1708 | Acquired | 3000799 | Indirect |
| 2018-11-20 | Common Stock, par value $0.01 | P | 20000 | $0.17 | Acquired | 3020799 | Indirect |
Footnotes
F1: These shares were purchased on the open market.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17